Flow Cytometry Could be Revolutionised by ChromaTwist

ChromaTwist Ltd., spin off of the University of Birmingham, has received £487 000 in equity funding to create novel fluorescent dyes for the flow cytometry reagents industry, which is predicted to be worth $2.9 bn by 2027.

The firm will use this to aid in product development, therefore accelerating the process of getting the dyes from initial stages to being commercially available on the market. ChromaTwist hopes to have the products up and running by next year.

Dye is used in flow cytometry to identify or quantify the properties of cells/ particles.

The capacity to identify numerous targets from the same sample, or “multiplexing,” is a primary difficulty in this field. With the help of this new solution, several testing on the same sample should be possible.

Professor Jon Preece said that they have “now moved to our own dedicated laboratory and will be expanding our team of scientists, so we can expedite our dye development for flow cytometry.”

“We expect the resulting dyes to be fully compatible with existing flow cytometry processes and equipment and are looking forward to the next 12 months working with industry partners.”

After proving that their offerings may be used as the active component in OPVs and OLED devices, ChromaTwist is looking at potential prospects in other industries, such as security inks and organic electronics. To achieve this, ChromaTwist traded 18 dyes to Sigma-Aldrich, a division of Merck’s Life Science branch. They’re also and is willing to have conversations with other businesses about possible instances where they can work together to fulfil mutually exclusive goals.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.